**Core tip:** Laparoscopy has been widely used in the treatment of colorectal cancer and has achieved a good radical effect in oncology. However, current clinical association guidelines do not recommend laparoscopic surgery for T4 colorectal cancer. This study retrospectively collected the data of pathological T4 (pT4) colorectal cancer patients at Guangdong General Hospital from 2006 to 2015, aiming to compare outcomes of laparoscopic *vs* open surgery. The conclusion is that laparoscopy is safely used in the treatment of pT4 colorectal cancer while offering advantages of faster recovery. Laparoscopy is able to achieve good oncologic outcomes similar to those of open surgery.

INTRODUCTION
============

Colorectal cancer is a common malignant tumor. It is the third most diagnosed cancer and the fourth leading cause of cancer-related deaths worldwide\[[@B1]\]. In China, the incidence and mortality of colorectal cancer are ranked among the top five of all cancers; thus, colorectal cancer is a very serious public health problem\[[@B2]\]. In promoting comprehensive, individualized, and precise treatments to date, surgical treatment is still the only way to cure colorectal cancer. Since 1991, when Jacobs first reported the technical feasibility of laparoscopic colectomy\[[@B3]\], a number of successful randomized controlled studies have been conducted around the world to compare laparoscopy and laparotomy, with encouraging results achieved. The laparoscopic treatment of colorectal cancer can not only achieve similar short- and long-term outcomes comparable to laparotomy, but its advantage of minimal invasiveness has gradually been recognized and promoted\[[@B4]-[@B7]\]. The American Joint Committee on Cancer (AJCC) classifies T4 colorectal cancers as those that invade into other organs and structures and/or perforate the visceral peritoneum; laparoscopic surgery in colorectal cancer at this stage is difficult as it is hard to reach and violates the "no touch" principle. Therefore, the AJCC and European Association of Endoscopic Surgery do not recommend laparoscopic treatment of pathological T4 (pT4) colorectal cancer\[[@B8]\]. This study retrospectively collected the data of pT4 colorectal cancer patients at Guangdong General Hospital from 2006 to 2015, aiming to compare the outcomes of laparoscopic *vs* open surgery.

MATERIALS AND METHODS
=====================

Patients
--------

All pT4 colorectal cancer patients treated at Guangdong General Hospital from 2006 to 2015 were enrolled in this study. All patients were staged according to the AJCC 7^th^ edition manual for colorectal cancer. The inclusion criteria included the following: (1) age of 18-75 years; (2) proven T4 pathology; and (3) radical surgery (D3 lymph node dissection). The exclusion criteria included the following: (1) low rectal cancer (peritoneal reflection as the boundary); (2) preoperative neoadjuvant treatment; (3) non-neoplastic deaths; and (4) palliative resection.

Surgical procedure
------------------

Preoperative computed tomography (CT) and magnetic resonance imaging were used to determine the preoperative clinical stage. The decision to proceed with laparoscopy or open surgery was made for all subjects on a patient-by-patient basis following multidisciplinary discussions and meetings. All cases entailed surgical resection according to the Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines\[[@B9]\], which have the following requirements: D3 lymph node dissection (Figure [1](#F1){ref-type="fig"}) to ensure the appropriate resection length, and ensuring that the integrity of the mesorectum and intraoperative operations follow the principle of "no touch" (sharp separation, blood vessels first, tumor isolation, *etc*.). According to tumor location, the method of resection included the following: total colectomy, right colectomy, extended right colectomy, transverse colectomy, left colectomy, sigmoid colectomy, mid/upper anterior resection, and combined organ resection. Laparoscopic incision should not exceed 6 cm. The conversion cases were analyzed in the open surgery (OPEN) group.

![Flowchart for selection of the extent of lymph node dissection (from reference 9).](WJG-24-76-g001){#F1}

Observation indexes
-------------------

The preoperative indexes included age, gender, body mass index (BMI; kg/m^2^), comorbidity, American Society of Anesthesiologists (ASA) score, tumor location, hemoglobin, and tumor markers (CA19-9 and CEA). The intraoperative indexes included surgical and pathological outcomes. Surgical outcomes included the conversion rate (conversion was defined as an open surgery performed during the laparoscopic procedure in order to ensure complete resection, reconstruction, or hemostasis and not just for the extraction of specimens), tumor size, resection length, operative time, blood loss, intraoperative complications, combined organ resection, postoperative complications and mortality. Pathological outcomes included the number of lymph nodes dissected, lymph node status, margin, pT stage, pN stage, pTNM stage, Dukes stage, histological subtype, and differentiation. The postoperative recovery indexes included time to flatus, diet, and ambulation and hospital stays.

Follow-up
---------

All patients were postoperatively referred to the 7^th^ AJCC/UICC TNM stage for adjuvant chemotherapy. All patients were followed through outpatient visits. According to the NCCN guidelines, patients were subjected to a 5-year surveillance program consisting of physical examinations and tumor marker (CEA and CA19-9) analysis every 3 mo up to 2 years. Every 6 mo, patients had complete colonoscopies at one and three years after surgery. Thoracic and abdominal CT scans were planned every year for five years of surveillance.

Statistical analysis
--------------------

Statistical analyses were performed using SPSS 19.0. Quantitative data are reported as the mean ± SD or median. Categorical data were compared by χ*^2^* tests or Fisher's exact test. Survival curves \[overall survival (OS) and disease-free survival (DFS)\] were derived from Kaplan-Meier estimates, and the curves were compared by the log-rank test. Prognostic factors were identified by univariate analysis and further tested by multivariate analysis. The results are reported as a hazard ratio (HR) with 95%CI. A *P-*value \< 0.05 was considered statistically significant.

RESULTS
=======

During the period from 2006 to 2015, we collected a total of 211 pT4a/bN0-2M0 cases according to enrollment criteria from 2308 cases of colorectal cancer at the Department of General Surgery of Guangdong General Hospital. There were 101 cases in the laparoscopy (LAP) group and 111 cases in the OPEN group (Figure [2](#F2){ref-type="fig"}).

![Study flowchart showing patient selection. GGH: Guangdong general hospital; pT4: Pathological proven T4.](WJG-24-76-g002){#F2}

There were no significant differences in age, gender, BMI, ASA score, tumor location, hemoglobin, CA19-9, or CEA between the two groups (*P* \> 0.05) (Table [1](#T1){ref-type="table"}).

###### 

Clinical information of 211 colorectal cancer cases

  **Clinical information**              **LAP**            **OPEN**       ***P* value**   
  ------------------------------------- ------------------ -------------- --------------- -------
  Age                                   \> 60 yr           55             58              0.270
  ≤ 60 yr                               46                 52                             
  Gender                                Male               67             66              0.392
  Female                                34                 44                             
  BMI (kg/m^2^)                         \< 24              67             73              0.348
  ≥ 24                                  34                 37                             
  Comorbidities                         Yes                39             42              1.000
  No                                    62                 68                             
  ASA score                             I                  8              9               0.715
  II                                    63                 72                             
  III                                   30                 29                             
  Tumor location                        Mid/upper Rectum   33             35              0.989
  Left colon                            43                 47                             
  Right colon                           25                 28                             
  HBG (g/L)                             mean ± SD          124.0 ± 27.1   120.7 ± 22.9    0.263
  CA19-9 (U/mL)                         \< 27              78             75              0.163
  ≥ 27                                  23                 35                             
  CEA (ng/mL)                           \< 5               60             64              0.666
  ≥ 5                                   41                 46                             
  Postoperative adjuvant chemotherapy   Yes                49             46              0.332
  No                                    52                 64                             
  Recurrence                            Yes                22             25              0.711
  No                                    79                 85                             

CRC: Colorectal cancer; LAP: Laparoscopic surgery group; OPEN: Open surgery group; BMI: Body mass index; ASA: American Society of Anesthesiology; HGB: Hemoglobin; CA19-9: Carbohydrate antigen 19-9; CEA: Caicinoembryonic antigen; SD: Standard deviation.

For surgical outcome, conversion to open surgery occurred in 15 (12.9%) patients, and all conversion cases were analyzed in the OPEN group. There was no significant difference between the two groups in terms of intraoperative complications and postoperative complications within 30 d (*P* \> 0.05). Laparoscopic surgery was slightly slower than open surgery (210.8 ± 88.9 min *vs* 173.5 ± 72.7 min, *P =* 0.028); there was less blood loss (155.0 ± 75.9 mL *vs* 235.1 ± 120.5 mL, *P =* 0.033) in laparoscopic surgery, whereas open surgery showed better resection lengths (15.5 ± 7.3 cm *vs* 19.5 ± 10.4 cm, *P =* 0.046). In the case of combined organ resection, there were 21 (19.1%) patients in the OPEN group, including three cases of abdominal wall resection, five cases of small bowel (except duodenum) resection, three cases of duodenum resection, two cases of urinary organ resection, one case of stomach resection, four cases of gynecologic organ resection, and three cases of liver resection; in contrast, there were only five cases in the LAP group (*P =* 0.001). For postoperative complications within 30 d, there were 12 (12.9%) cases in the LAP group, and there was a higher incidence in the OPEN group (31.8%, *P =* 0.006) (Table [2](#T2){ref-type="table"}).

###### 

Surgical outcomes of 211 colorectal cancer cases

  **Surgical outcome**                                                      **LAP**        **OPEN**        ***P* value**
  ----------------------------------------- ------------------------------- -------------- --------------- ---------------
  Conversion to open (*n*/%)                                                15 (12.9)      NR              /
  Tumor size (cm)                           mean ± SD                       5.4 ± 1.9      5.2 ± 2.5       0.765
  Resection length (cm)                     mean ± SD                       15.5 ± 7.3     19.5 ± 10.4     0.046
  Operative time (min)                      mean ± SD                       210.8 ± 88.9   173.5 ± 72.7    0.028
  Blood loss (mL)                           mean ± SD                       155.0 ± 75.9   235.1 ± 120.5   0.033
  Intraoperative complications                                              3              8               0.117
  Combined organ resection                  Total (%)                       5 (5.0)        21 (19.1)       0.001
                                            Abdominal wall                  2              3               
                                            Small bowel (except duodenum)   1              5               
                                            Duodenum                        0              3               
                                            Urinary organs                  0              2               
                                            Stomach                         1              1               
                                            Gynecologic organs              1              4               
                                            Liver                           0              3               
  Postoperative complications within 30 d   Total (%)                       12 (12.9)      35 (31.8)       0.006
                                            Anastomotic Hemorrhage          1              2               
                                            Urinary injury                  0              1               
                                            Intraabdominal bleeding         1              2               
                                            Leakage                         1              4               
                                            Gastroplegia                    2              4               
                                            Infection                       6              15              
                                            (incision and abdomen)                                         
                                            Disruption of incision          0              5               
                                            Obstruction                     1              2               
  Postoperative morbidity within 30 d                                       0              1               0.667

CRC: Colorectal cancer; LAP: Laparoscopic surgery group; OPEN: Open surgery group.

Regarding pathologic outcomes, no significant differences in the number of lymph nodes dissected, lymph node status, margin, pN stage, pTNM stage, Dukes stage, histological subtype, differentiation, or HER2 status were detected when comparing the two groups (*P* \> 0.05). There were 21 pT4b cases in the OPEN group but only five cases in the LAP group; a comparison between the two groups in the pT stage revealed a statistically significant difference (*P =* 0.021) (Table [3](#T3){ref-type="table"}).

###### 

Pathologic outcomes of 211 colorectal cancer cases

  **Pathologic outcome**            **LAP**          **OPEN**   ***P* value**   
  --------------------------------- ---------------- ---------- --------------- -------
  Number of lymph nodes dissected   \< 12            25         38              0.134
  ≥ 12                              76               72                         
  Lymph node status                 \+               67         74              1.000
  \-                                34               36                         
  Margin                            R1               2          3               0.779
  R0                                99               107                        
  pT stage                          T4a              96         89              0.021
  T4b                               5                21                         
  pN stage                          N0               36         35              0.841
  N1                                28               32                         
  N2                                37               43                         
  pTNM stage                        IIB + IIC        34         35              0.282
  IIIB                              30               24                         
  IIIC                              37               51                         
  Dukes                             B                34         35              0.883
  C                                 67               75                         
  Histological subtype              Adenocarcinoma   87         94              1.000
  Myxoadenocarcinoma                14               16                         
  Differentiation                   Poor             20         25              0.719
  Median/high                       81               85                         
  HER2                              -/+              86         96              0.871
  ++                                10               10                         
  +++                               5                4                          

CRC: Colorectal cancer; LAP: Laparoscopic surgery group; OPEN: Open surgery group; SD: Standard deviation; p: Pathological.

With regard to postoperative recovery indexes, the LAP group was significantly better than the OPEN group (*P \<* 0.05) in time to flatus, diet, and ambulation. The median hospital stay was 7 (5-21) d for the LAP group and 15 (7-31) d for the OPEN group, which showed a statistically significant difference between the two groups (*P =* 0.004) (Table [4](#T4){ref-type="table"}).

###### 

Postoperative recovery outcomes of 211 colorectal cancer cases

  **Recovery outcome**                      **LAP**    **OPEN**    ***P* value**
  ------------------------ ---------------- ---------- ----------- ---------------
  Time to flatus (d)       Median (range)   2 (1-9)    4 (3-15)    0.037
  Time to diet (d)         Median (range)   3 (2-18)   7 (5-27)    0.003
  Time to ambulation (d)   Median (range)   2 (1-5)    5 (3-9)     0.027
  Hospital stays           Median (range)   7 (5-21)   15 (7-31)   0.004

LAP: Laparoscopic surgery group; OPEN: Open surgery group.

The mean overall follow-up time was 36 mo (range, 2-24 mo); there was no difference between the LAP and OPEN groups in terms of OS and DFS. The 3- and 5-year OS rates were 74.9% and 60.5%, respectively, for the LAP group and 62.4% and 46.5%, respectively, for the OPEN group (*P =* 0.60) (Figure [3](#F3){ref-type="fig"}). The 3- and 5-year DFS rates were 68.0% and 57.3%, respectively, for the LAP group and 55.8 and 39.8%, respectively, for the OPEN group (*P =* 0.053) (Figure [4](#F4){ref-type="fig"}). Disease recurrence over the entire follow-up period was observed in 21.8% (*n* = 22) of patients in the LAP group and 22.7% (*n* = 25) of patients in the OPEN group (*P =* 0.711) (Table [1](#T1){ref-type="table"}), without significant differences between the LAP and OPEN groups (*P =* 0.711). In the multivariate regression analysis, TNM stage (IIIB, IIIC), lymph node status (pN+), and CA19-9 were significant predictors of OS. TNM stage (IIIC), histological subtype, CA19-9, and chemotherapy were predictive of DFS (Tables [5](#T5){ref-type="table"} and [6](#T6){ref-type="table"}).

![The overall survival curve shows that 3- and 5-year overall survival rates were 74.9% and 60.5%, respectively, in the LAP group and 62.4% and 46.5%, respectively, in the OPEN group. There was no significant difference between the LAP and OPEN groups (*P* = 0.060).](WJG-24-76-g003){#F3}

![The disease-free survival curve shows that the 3- and 5-year disease-free survival rates were 68.0% and 57.3%, respectively, in the LAP group and 55.8% and 39.8%, respectively, in the OPEN group. There was no significant difference between the LAP and OPEN groups (*P* = 0.053).](WJG-24-76-g004){#F4}

###### 

Univariate and multivariate analyses of 211 pathological T4 colorectal cancer patients for overall survival

                                   **Univariate analysis**   **Multivariate analysis**                         
  -------------------------------- ------------------------- --------------------------- --------------------- -------
  Age                              1.217 (0.784-1.888)       0.381                                             
  Gender                           0.807 (0.508-1.281)       0.363                                             
  Surgical method (LAP and OPEN)   1.528 (0.982-2.377)       0.060                                             
  Tumor location                                                                                               
  Mid/upper rectum                 Reference group           \-                                                
  Left colon                       1.303 (0.813-2.091)       0.272                                             
  Right colon                      0.792 (0.409-1.533)       0.489                                             
  Comorbidities                    1.603 (1.007-2.552)       0.047                       2.519 (1.436-4.419)   0.142
  pT4a/b                           0.790 (0.692-1.236)       0.445                                             
  N stage                                                                                                      
  N0                               Reference group           \-                                                
  N1                               1.328 (0.701-2.517)       0.384                                             
  N2                               2.079 (1.170-3.697)       0.013                                             
  TNM stage                                                                                                    
  IIB + IIC                        Reference group           \-                          Reference group       \-
  IIIB                             1.229 (0.564-2.679)       0.604                       1.324 (0.785-1.753)   0.019
  IIIC                             3.092 (1.617-5.913)       0.001                       1.104 (0.333-3.662)   0.001
  Lymph node status                0.560 (0.324-0.968)       0.038                       0.307 (0.103-0.919)   0.035
  No. of lymph nodes resected      0.593 (0.385-0.915)       0.018                       0.432 (0.264-0.708)   0.123
  Histological subtype             0.369 (0.212-0.640)       0.000                       0.433 (0.218-0.859)   0.247
  Differentiation                  0.326 (0.204-0.519)       0.000                       0.460 (0.273-0.775)   0.087
  CA19-9                           1.868 (1.195-2.922)       0.006                       1.662 (1.212-2.280)   0.002
  CEA                              1.089 (0.706-1.680)       0.013                       0.608 (0.356-1.038)   0.068
  Chemotherapy                     1.611 (1.040-2.494)       0.033                       2.225 (1.394-3.552)   0.181

CRC: Colorectal cancer; LAP: Laparoscopy surgery; OPEN: Open surgery; p: Pathological; CA19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen; HR: Hazard ratio.

###### 

Univariate and multivariate analyses of 211 pathological T4 colorectal cancer patients for disease-free survival

                                   **Univariate analysis**   **Multivariate analysis**                         
  -------------------------------- ------------------------- --------------------------- --------------------- -------
  Age                              1.621 (1.010-2.601)       0.045                       1.892 (1.111-3.223)   0.419
  Gender                           1.328 (0.824-2.141)       0.243                                             
  Surgical method (LAP and OPEN)   1.503 (0.933-2.422)       0.094                                             
  Tumor location                                                                                               
  Mid/upper rectum                 Reference group           \-                                                
  Left colon                       1.010 (0.601-10697)       0.969                                             
  Right colon                      0.818 (0.411-1.629)       0.568                                             
  Comorbidities                    1.787 (1.058-3.019)       0.030                       2.261 (1.235-4.139)   0.080
  pT4a/b                           0.818 (0.618-1.725)       0.013                       1.214 (0.784-1.974)   0.001
  N stage                                                                                                      
  N0                               Reference group           \-                                                
  N1                               1.134 (0.594-2.167)       0.703                                             
  N2                               1.553 (0.861-2.801)       0.144                                             
  TNM stage                                                                                                    
  IIB + IIC                        Reference group           \-                          Reference group       \-
  IIIB                             1.034 (0.471-2.269)       0.933                       0.884 (0.393-1.989)   0.765
  IIIC                             2.284 (1.202-4.337)       0.012                       1.831 (0.935-3.584)   0.018
  Lymph node status                0.710 (0.411-1.229)       0.221                                             
  No. of lymph nodes resected      0.661 (0.411-1.061)       0.087                                             
  Histological subtype             0.456 (0.243-0.854)       0.014                       0.469 (0.225-0.974)   0.042
  Differentiation                  0.439 (0.266-0.725)       0.001                       0.662 (0.374-1.170)   0.156
  CA19-9                           2.458 (1.526-3.960)       0.000                       3.372 (1.968-5.778)   0.000
  CEA                              1.268 (0.790-2.036)       0.326                       0.608 (0.356-1.038)   0.072
  Chemotherapy                     2.157 (1.323-3.514)       0.002                       3.817 (2.194-6.639)   0.000

CRC: Colorectal cancer; LAP: Laparoscopic surgery; OPEN: Open surgery; p-Pathological; CA19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen; HR: Hazard ratio.

DISCUSSION
==========

Since the first report of laparoscopic colorectal resection in 1991, some prospective clinical studies of laparoscopic resection for colorectal cancer have confirmed that laparoscopic techniques not only achieve minimally invasive and cosmetic effects but also achieve faster recovery and similar oncologic outcomes compared with open surgery\[[@B10]-[@B12]\]. However, due to the large tumor size of T4 colorectal cancer and more frequent invasion of peripheral tissues or nearby organs, laparoscopic complete resection is difficult and has high risks; the majority of clinical studies have fewer cases of T4 colorectal cancer\[[@B13],[@B14]\], and some studies do not enroll any such cases\[[@B15],[@B16]\]. Therefore, the evidence-based data that support the laparoscopic resection in T4 colorectal cancer are limited. Laparoscopic resection of T4 colorectal cancer is regarded a technique that demands precision, and its efficacy remains controversial. The relevant guidelines do not recommend laparoscopy in T4 colorectal cancer\[[@B8]\]. However, due to the maturity and progress of the laparoscopic platform, coupled with the popularity of and improvements in laparoscopic techniques, some surgeons in certain experienced centers have tried to use laparoscopic techniques in T4 colorectal cancer, achieving similar short- and long-term outcomes to open surgery\[[@B17]-[@B20]\].

This study decided whether laparoscopic or open surgery should be performed based on the results of preoperative imaging examination and the patient's condition; the main referenced indicators included the following: tumor location, tumor size, and the scope of invaded organ\[[@B21]\]. We found a statistically significant difference in the postoperative pT stage between the two groups (*P =* 0.021), with 21 cases of pT4b in the OPEN group. An examination of postoperative surgical outcomes (Table [2](#T2){ref-type="table"}) revealed 21 cases of combined organ resection in the OPEN group, with the most commonly invaded organs including the small intestine, gynecological organs, and duodenum; in contrast, the LAP group had only five cases, and the number of cases of combined organ resection was thus significantly different for the two groups (*P =* 0.001), which is consistent with the results of previous studies\[[@B22],[@B23]\]. These data also demonstrate that T4b stage may be an important consideration for surgeons to select laparoscopic or open surgery because it is very difficult to achieve the goal of complete resection using the "no touch" principle; therefore, guidelines do not recommend laparoscopic resection in T4 colorectal cancer\[[@B8]\]. However, such considerations lead to selective bias in the study, which is one of the limitations in both this study and a retrospective study.

Because of the larger tumor, a wide scope of invasion, combined with resection of other organs, especially due to the lack of laparoscopic experience in some centers, may lead to a high conversion rate. Previous studies of laparoscopic surgery in colorectal cancer (stage II-III)\[[@B11],[@B15],[@B24]\] reported that the conversion rate was 25% in the CLASSIC trial (for colon cancer), 17% in the COLOR trial, and 21% in the COSTSG trial, whereas a retrospective study of pT4 colorectal cancer showed that the conversion rate was 5.6%-24.7%\[[@B17],[@B19],[@B22],[@B25]-[@B29]\]; this study showed a conversion rate of 12.9%, which is consistent with reports in the literature. The conversion rates reported by some studies of pT4 colorectal cancer in South Korea and Singapore were 5.6%, 7.7% and 8.6%\[[@B22],[@B29],[@B30]\], which are significantly lower than those from the US and Europe\[[@B17],[@B18],[@B25],[@B27]\] (Table [7](#T7){ref-type="table"}). We explain these differences as follows: (1) Laparoscopic technology and experience may differ between Asian and Western countries; (2) the conversion standard used was different; (3) there was a lack of preoperative imaging assessments to select appropriate laparoscopic surgery cases in Western countries; and (4) European populations had a higher BMI. All these factors increase the difficulty of surgery\[[@B17]-[@B25]\]. Thus, surgeons should choose the appropriate pT4 colorectal cases to perform laparoscopic surgery in order to reduce the conversion rate and ensure operation safety. We recommend laparoscopic surgery as an option in experienced centers and for T4a cases with tumor sizes \< 5 cm and when only a single organ has been invaded by T4 colorectal cancer.

###### 

Studies about laparoscopic surgery for pathological T4 colorectal cancer

  **Ref**.                           ***n* (LAP:OPEN)**   **Study period**   **Study design**   **Country**     **Single/Multi center**   **Conversion rate**   **Location**   **Complication rate (LAP:OPEN)**   **Tumor stage**   **Combined resection (LAP:OPEN)**   **RI rate** **(LAP:OPEN)**   **5 years DFS (LAP:OPEN)**   **5 years OS (LAP:OPEN)**
  ---------------------------------- -------------------- ------------------ ------------------ --------------- ------------------------- --------------------- -------------- ---------------------------------- ----------------- ----------------------------------- ---------------------------- ---------------------------- ---------------------------
  Park et al\[[@B22]\], 2016         93:18                2000-2010          RS                 South Korea     Single                    5.6%                  Colon          14.1%:31.5%                        \-                9.9%:32.5%                          5.5%:4.5%                    81.8%:73.9%                  95.3%:86.5%
  rectum                                                                                                                                                                                                                                                                                                                          
  Shukla et al\[[@B20]\], 2015       61:22                2003-2011          RS                 United States   Single                    21%                   Colon          28%:36%                            II:35             23%:41%                             0%:4%                        75%:65%                      82%:81%
  III:48                             (3 yr)               (3 yr)                                                                                                                                                                                                                                                                  
  Kang et al\[[@B29]\], 2016         52:57                2003-2013          RS                 South Korea     Single                    7.7%                  Colon          13.5%:36.8%                        II:41             13.5%:36.8%                         \-                           53.6%:62.6%                  60.7%:61.9%
  III:68                                                                                                                                                                                                                                                                                                                          
  de'Angelis et al\[[@B18]\], 2016   106:106              2005-2014          RPSM               France          Multi                     12.2%                 Colon          29.1%:35.3%                        II:85             14.2%:18.9%                         5.7%:6.6%                    58.6%:59.9%                  57.6%:50.2%
  Switzerland                        III:127                                                                                                                                                                                                                                                                                      
  de'Angelis et al\[[@B17]\], 2016   52:52                2005-2015          RPSM               France          Multi                     21.2%                 Rectum         30.8%:48.1%                        II:42             26.9%:30.8%                         19.2%:17.3%                  66.7%:64.1%                  55.4%:53.3%
  Switzerland                        III:33                                                                                                                                                                                                                                                                                       
  Spain                              IV:29                                                                                                                                                                                                                                                                                        
  Chan et al\[[@B30]\], 2016         93:59                2008-2014          RS                 Singapore       Single                    8.6%                  Colon          \-                                 \-                0%:3.4%                             0%:0.7%                      \-                           75%:80%
  Leon et al\[[@B27]\], 2017         68:79                2008-2015          RS                 Italy           Single                    19%                   Colon          7.4%:16.5%                         II:69             \-                                  11.8%:11.5%                  40.3%:38.9%                  44.6%:39.4%
  III:78                                                                                                                                                                                                                                                                                                                          
  Ahmad et al\[[@B25]\], 2015        455:406              2011-2012          RS                 Canada          ACSNS                     24.7%                 Colon          \-                                 \-                \-                                  26.2%:24.3%                  \-                           \-
  QIP                                                                                                                                                                                                                                                                                                                             

LAP: Laparoscopy; RS: Retrospective study; RPSM: Retrospective propensity score matching; ACSNS: American College of Surgeons National Surgical Quality Improvement Program; OS: Overall survival; DFS: Disease-free survival.

In this study, the LAP group had longer operative time (210.8 ± 88.9 min *vs* 173.5 ± 72.7 min, *P =* 0.028), which may be related to the lack of experience and the difficulty of this surgery\[[@B19]\]. The resection length (19.5 ± 10.4 cm) obtained in the OPEN group was significantly better (*P =* 0.046). The literature shows that the incidence of postoperative complications associated with laparoscopic surgery was clearly lower than that associated with open surgery\[[@B31]\]. In this study, the rate of postoperative complication within 30 d in the LAP group was 12.9% (12/101), which was lower than 31.8% (35/110) in the OPEN group, and the most common complications in the OPEN group were infection (incision and abdomen) and disruption of incision, similar to a previous report in the literature\[[@B32]\]. Therefore, attention should be paid to intraoperative sterile principles and the suture of incision.

With regard to postoperative recovery outcomes, the LAP group had clear advantages in time to flatus (*P =* 0.037), diet (*P =* 0.003), and ambulation (*P =* 0.027) and hospital stays (*P =* 0.004) compared with the OPEN group (Table [4](#T4){ref-type="table"}). Laparoscopy has the advantages of minimal invasion and fast recovery, which is in agreement with many earlier clinical studies\[[@B12],[@B15],[@B16]\].

In colorectal cancer surgery, lymph node dissection and R0 resection are important factors affecting long-term survival\[[@B33]\]. We performed D3 lymphadenectomy (parenteral lymph node -middle lymph node-central lymph node)\[[@B34]\] according to the guidelines recommended by the JSCCR. Previous studies have shown that laparoscopic treatment of colorectal cancer achieved an R0 resection rate between 80.8% and 98%\[[@B11],[@B16],[@B18]\]. In this study, the percentage of cases with the number of lymph nodes dissected greater than 12 was 75.2% (76/101) in the LAP group and 65.5% (72/110) in the OPEN group, and the difference was not significantly different (*P =* 0.134). Concurrently, the R0 resection rate in the LAP group was 98% (99/101), whereas in the OPEN group, it was 97.3% (107/110), which was not significantly different (*P =* 0.779). Thus, we believe that laparoscopic treatment in pT4 colorectal cancer can achieve similar oncological outcomes to open surgery. Finally, no differences in the 3- and 5-year OS rates (*P =* 0.060) and in 3- and 5-year DFS rates (*P =* 0.053) were observed when comparing the two groups, suggesting that laparoscopy may be a valid and effective tool to treat pT4 colorectal cancer without jeopardizing oncologic results, in accordance with the previously reported series. Multivariate analysis in our series detected IIIB/IIIC stage, lymph node status, and CA19-9 as independent predictors of OS, and pT4a/b, IIIC stage, CA19-9, and adjuvant chemotherapy as independent predictors of DFS.

In conclusion, laparoscopic surgery may be safe and acceptable in the treatment of pathologic T4 colorectal cancer patients with fast recovery outcomes and oncologic outcomes compared with open surgery. Thus, laparoscopy should not be regarded as an absolute contraindication in the management of pT4 colorectal cancer. Finally, as this study is only a retrospective study in a single center with a small sample size, the results need to be confirmed by prospective, multi-center and large sample clinical studies.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

Laparoscopy has been widely used in the treatment of colorectal cancer and it has achieved a good radical effect in oncology. However, for the current clinical guidelines, laparoscopic surgery is not recommended in T4 colorectal cancer.

Research motivation
-------------------

Due to the characteristics of T4 colorectal cancer, laparoscopic complete resection is difficult for the resection of this kind of tumor. The current colorectal studies about laparoscopy have fewer cases of T4 colorectal cancer, and some studies do not enroll any such cases. We tried to collect and analyze the data about laparoscopy in T4 colorectal cancer in order to add evidence-based clinical evidence.

Research objectives
-------------------

We aimed to analyze the short- and long-term outcomes of proven pathological T4 colorectal cancer patients who underwent complete resection by laparoscopic or open surgery.

Research methods
----------------

We collected and analyzed the data of pT4 colorectal cancer cases at Guangdong General Hospital from 2006 to 2015. All patients were staged according to the AJCC 7th edition manual for colorectal cancer. We compared the laparoscopy (LAP) group and open (OPEN) group in clinical information, surgical and pathological outcomes, postoperative recovery outcomes, and survival.

Research results
----------------

There were 101 cases in the LAP group and 110 cases in the OPEN group \[including15 (12.9%) cases of conversion to open surgery\]. Clinical information did not differ between the two groups. In terms of blood loss, postoperative complications, and rate of recovery, the LAP group performed significantly more favorably (*P \<* 0.05). With regard to pT4a/b and combined organ resection, there were significantly more cases in the OPEN group (*P* \< 0.05). The 3- and 5-year overall survival rates were 74.9% and 60.5%, respectively, for the LAP group and 62.4% and 46.5%, respectively, for the OPEN group (*P =* 0.060). The 3- and 5-year disease-free survival rates were 68.0% and 57.3%, respectively, for the LAP group and 55.8% and 39.8%, respectively, for the OPEN group (*P =* 0.053). Multivariate analysis showed that IIIB/IIIC stage, lymph node status, and CA19-9 were significant predictors of overall survival. PT4a/b, IIIC stage, histological subtype, CA19-9, and adjuvant chemotherapy were independent factors affecting disease-free survival.

Research conclusions
--------------------

Laparoscopic surgery may be safe and acceptable in the treatment of pathologic T4 colorectal cancer patients with fast recovery outcomes and oncologic outcomes compared with open surgery. We recommend that it can be carried out in experienced centers. It is required to screen the appropriate cases for laparoscopic surgery, optimize the preoperative diagnosis process, and reduce the conversion rate.

Research perspectives
---------------------

Although our study shows that laparoscopy is able to achieve good clinicopathological and oncologic outcomes similar to those of open surgery, this study is only a retrospective study in a single center with a small sample, and the results need to be confirmed by prospective, multi-center and large sample clinical studies.
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